Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in AdolescentsLong-Term Outcomes with Medications for Attention-Deficit Hyperactivity DisorderThe long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trialsInfluence of methylphenidate on brain development--an update of recent animal experiments.Outcome domains in child mental health research since 1996: have they changed and why does it matter?Functional consequences of attention-deficit hyperactivity disorder on children and their families.Quantifying the relationship between perceived consequences of ADHD medication and its usage.ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility studyBeliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorderDopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorderThe effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.Exasperating or exceptional? Parents' interpretations of their child's ADHD behavior.Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.Attention deficit/hyperactivity disorder: pharmacotherapy.Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades.Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid programMedication refusal in children with oppositional defiant disorder or conduct disorder and comorbid attention-deficit/hyperactivity disorder: medication history and clinical correlatesImpact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis.Sleep disturbances in children with attention-deficit/hyperactivity disorderRelationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspectiveExploring stimulant treatment in ADHD: narratives of young adolescents and their parents.An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherenceManaging attention deficit/hyperactivity disorder: unmet needs and future directionsOmega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.The effects of long-term medication on growth in children and adolescents with ADHD: an observational study of a large cohort of real-life patientsDiet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD.The epidemiology of psychotropic drug use in children and adolescents.Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategiesDiagnosing and treating attention-deficit/hyperactivity disorder in adults.Injury among stimulant-treated youth with ADHD.
P2860
Q22061981-0211BD88-5C4E-4529-9312-C3B23D7E30F2Q22241419-7AD1D790-85D4-4A68-8E82-0185179B9827Q22241421-B09B7891-A4AD-471B-98F2-9543B6E7054BQ22241444-3971FB3E-5869-48F3-8D60-9B9646495DE0Q24537917-4DA2CE21-183F-4B13-83EB-7E36950BBAC0Q26822028-A034491E-8214-4A61-A7C4-21841FBFE171Q30251626-7A10FC6D-48EF-45EB-A69F-6D6F7FB93071Q30455992-F116B666-4D36-4589-835C-0ACD638BD91DQ30498399-343DB761-2B47-45B2-A823-680D908E0AE3Q33571522-61EE5E88-BF3F-4FB9-8E55-D74618967A14Q33782844-D1D194FE-FD4A-4D4F-B52C-979A88C92B9DQ33799533-E4A728D7-4E41-44F3-9AF7-28BE8C513DD0Q33870580-B19BC8B6-5E11-48BD-8F99-93E35E8D2771Q33926699-0A550181-023D-457F-A4DB-84FD098632FAQ34233624-586E16A4-67D5-4A9D-9A4C-5FB6280F69B3Q34240468-D2215E88-5D8F-4916-A0B1-9786182F4067Q34362939-EB41BD18-13DA-4A1F-A7CA-D2045EDBB3ADQ34418634-49CFCBFA-85C3-4436-AEB2-CB4EE5212735Q34440332-C690EEFC-DCA8-4775-B020-752AC235450AQ34476693-D22FBF2E-9782-4645-B7A7-7619DB7CDDC6Q34566730-E9DD99CB-1FBD-4D29-BB44-246E01801B24Q34619814-5D0A5C8B-6E83-4BFC-8817-E8AB0E038468Q35086494-AE4C24F0-287C-4419-8726-8AD56198BC2EQ35123049-D6F75363-6D23-4126-835F-EAD20B6D8E73Q35146170-3A89BD0E-10BE-4FA8-BC9A-263072A2A988Q35233612-C90E0A80-81E0-4EA9-8846-77D9C20D8725Q35575707-9A79CD64-437F-44A0-93B6-05967B3443C7Q36032585-0F51D9E0-9CE7-4531-BE56-7D3360CC8A67Q36086314-F3710121-1688-4972-B1F1-B5EB4F909883Q36220220-3D850E70-9F91-4683-8EB7-F8612666F14CQ36259685-5AC59253-1D14-4F14-A51A-CFDB65038CC6Q36272506-E6C11EBF-CD71-45CE-847D-BB89794F52E3Q36276018-9EA02ADC-DDA8-495C-B9B2-F70D9957808DQ36453293-CBCEB254-589D-4098-8FEA-19877DBC560CQ36649094-3D19A11F-B577-4283-97AD-FBFE6400172DQ36699910-A20C1704-57D5-4701-925F-4FFD67C03018Q36731199-AAEA8DBD-356E-4C84-A2F1-8274D4094FA5Q36740445-C47D7967-7EB1-4AC3-94BC-D4A210273C51Q36919939-1AE8BA1C-D936-4496-8F98-2A860EA28EB3Q36969976-998ED6E1-D6ED-4768-A3B6-D8FE81C3B157
P2860
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@en
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@nl
type
label
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@en
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@nl
prefLabel
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@en
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@nl
P1476
Stimulant treatment over five years: adherence, effectiveness, and adverse effects.
@en
P2093
Abel Ickowicz
Alice Charach
P304
P356
10.1097/00004583-200405000-00009
P577
2004-05-01T00:00:00Z